Back to search

Article

NTR 2.0: a rationally-engineered prodrug converting enzyme with substantially enhanced efficacy for targeted cell ablation

2020-05-24

Abstract excerpt

<h4>ABSTRACT</h4> Heterologously-expressed bacterial nitroreductase (NTR) enzymes sensitize eukaryotic cells to prodrugs such as metronidazole (MTZ), enabling selective cell ablation paradigms that have expanded studies of cell function and regeneration in vertebrate systems. However, first-generation NTRs require confoundingly toxic prodrug treatments (e.g. 10 mM MTZ) and some cell types have proven resistant. W...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
0bdd88f5-2787-502c-ad80-5018064b297a
DOI
10.1101/2020.05.22.111427
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
NTR 2.0: a rationally-engineered prodrug converting enzyme with substantially enhanced efficacy for targeted cell ablationDOI 10.1101/2020.05.22.111427
Select a neighboring publication to make it the new centre.